Tag: said-on-monday
-
Astellas, Vical herpes vaccine fails mid-stage study
(Reuters) – Japan’s Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients. Vical’s shares was down about 18 percent in light premarket trading on Monday. The DNA vaccine, ASP0113, is designed to prevent cytomegalovirus (CMV) disease in patients receiving a renal transplant…
-
Cycling-Data leak boosts Froome, puts Wiggins in spotlight
By Alan Baldwin LONDON, Sept 19 (Reuters) – Chris Froome’s credibility as triple Tour de France champion has only been boosted by the hacking of his private medical information, according to a South African physiologist who carried out tests on the Briton last year. Jeroen Swart, in an interview with the Cycling Tips website, suggested,…
-
Global ad spend strengthens on U.S. demand: Zenith
Spending on global advertising will grow by a better-than-expected 4.4 percent this year, led by the United States, a leading forecaster said on Monday. Zenith, owned by France's Publicis , raised its global growth forecast for this year from the 4.1 percent it predicted in June, despite the uncertainty sparked by Britain's vote to leave…
-
Hillary Clinton’s health re-emerges as issue in ’16 campaign
WASHINGTON (AP) — Hillary Clinton's stumbles as she left Sunday's 9/11 memorial ceremony in New York put her health at the forefront of a presidential campaign in which the two major party nominees are among the oldest ever and have disclosed limited information about their medical history.
-
Saudi-led coalition raids kill at least 21 in Yemen: residents
At least 21 civilians were killed in two separate air strikes by the Saudi-led coalition in northern Yemen on Saturday, residents said on Sunday, as fighting intensified in the country before the Muslim Eid al-Adha feast. At least 15 civilians were killed when war planes struck workers drilling for water in the Beit Saadan area…
-
Bayer sweetens Monsanto bid as talks enter final stretch
German pharmaceutical and crops manufacturer Bayer AG said on Monday that its negotiations with Monsanto Co had advanced, and it was now willing to offer more than $65 billion to acquire the world's largest seed company. Bayer's announcement came as the gap in price expectations between the two companies has narrowed significantly, although important terms,…
-
Bayer sweetens Monsanto bid as talks enter final stretch
German pharmaceutical and crops manufacturer Bayer AG said on Monday that its negotiations with Monsanto Co had advanced, and it was now willing to offer more than $65 billion to acquire the world's largest seed company. Bayer's announcement came as the gap in price expectations between the two companies has narrowed significantly, although important terms,…
-
Bayer sweetens offer for Monsanto
(Reuters) – German drugmaker Bayer AG said on Monday it was in advanced talks to acquire Monsanto Co and was raising its offer for the U.S. seed producer. Bayer said it would be prepared to offer $127.50 per Monsanto share from its previous offer price of $125 per share only in connection with a negotiated…
-
Bayer sweetens offer for Monsanto
(Reuters) – German drugmaker Bayer AG said on Monday it was in advanced talks to acquire Monsanto Co and was raising its offer for the U.S. seed producer. Bayer said it would be prepared to offer $127.50 per Monsanto share from its previous offer price of $125 per share only in connection with a negotiated…